Novo Nordisk ends authorized proceedings in opposition to Hims & Hers
Novo Nordisk has dropped its legal proceedings against the telemedicine provider Him and him for patent infringement after the two companies agreed that Hims would sell Novo's branded drugs through its platform. "We have decided to…